Related Experiment Videos
Nuclear cytometric changes in breast carcinogenesis
E C Mommers1, N Poulin, J Sangulin
1Department of Pathology, Free University Hospital, Amsterdam, The Netherlands.
The Journal of Pathology
|February 13, 2001
Summary
This study quantifies nuclear changes in breast tissue, revealing distinct progression pathways for well-differentiated and poorly differentiated breast cancers from precursor lesions. Florid ductal hyperplasia may represent an advanced stage with cancer precursor cells.
Area of Science:
- Oncology
- Pathology
- Biomedical Imaging
Background:
- Breast cancer development is hypothesized to involve a series of precursor lesions with increasing morphological alterations.
- Understanding these early changes is crucial for identifying cancer development pathways.
Purpose of the Study:
- To quantitatively analyze nuclear features using image cytometry across the spectrum of breast proliferative lesions, from normal tissue to invasive carcinoma.
- To objectively describe nuclear changes and elucidate progression routes in intraductal and invasive breast lesions.
Main Methods:
- Image cytometry was applied to tissue sections from normal breast tissue, usual ductal hyperplasia (UDH), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) (well- and poorly differentiated), and invasive breast carcinomas (well- and poorly differentiated).
Main Results:
- Progressive nuclear feature changes were observed from normal tissue to invasive carcinoma.
- Florid ductal hyperplasia showed significant nuclear differences compared to mild/moderate UDH, suggesting it may be a more advanced precursor.
- No significant nuclear differences were found between ADH and well-differentiated DCIS, indicating a close relationship.
- Nuclear features of well-differentiated DCIS mirrored those of well-differentiated invasive carcinoma, and similarly for poorly differentiated lesions.
Conclusions:
- Image cytometry effectively demonstrates progressive nuclear changes in breast lesions, supporting a pathway from UDH to ADH to invasive cancer.
- Distinct progression routes exist for well-differentiated (via well-differentiated DCIS) and poorly differentiated (via poorly differentiated DCIS) invasive breast cancers.